|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Molecular Pharmacology & Toxicology, University of Southern California School of Pharmacy, Los Angeles, CA, USA
2 Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA, USA
3 Molecular Pharmacology & Toxicology, University of Southern California School of Pharmacy, Los Angeles, CA, USA; Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA; Will Rogers Institute Pulmonary Research Center, University of Southern California, Los Angeles, CA, USA
4 Department of Pharmacology and Experimental Therapeutics, University of Maryland, Baltimore, MD, USA
5 Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA, USA; Division of Surgical, Therapeutics, and Bioengineering Sciences, University of Southern California School of Dentistry, Los Angeles, CA, USA
6 Molecular Pharmacology & Toxicology, University of Southern California School of Pharmacy, Los Angeles, CA, USA; Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA; Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA, USA
* To whom correspondence should be addressed. E-mail: ann{at}usc.edu.
We recently showed that Etk/Bmx, a member of the Tec family of non-receptor tyrosine protein kinases, promotes tight junction formation during chronic hypoxic exposure and augments normoxic VEGF expression via a feedforward mechanism. In this study, we further characterized the role of Etk in potentiating hypoxia-induced gene expression in salivary epithelial Pa-4 cells. Using transient transfection in conditionally activated Etk (i.e.,
Etk:ER) cells, we demonstrated that Etk enhances hypoxia-response element (HRE)-dependent reporter activation in both nonhypoxic and hypoxic conditions. This Etk driven reporter activation is ameliorated by the treatment of either Wortmannin or LFM-A13. Furthermore, by employing lentiviral-mediated gene delivery and siRNA technology, we provided direct evidence that hypoxia leads to a transient activation of both Etk and Akt, and that the activation of hypoxia-mediated Akt activation is Etk-dependent. Northern analyses confirmed that Etk activation led to the induction of steady-state mRNA levels of endogenous VEGF and PAI-1, a hallmark of hypoxia-mediated gene regulation. We also demonstrated that Etk utilizes a PI3-K/Akt pathway to promote reporter activation driven by NF-
B, another oxygen-sensitive transcription factor, and to augment cytokine-induced iNOS expression in endothelial cells. In order to establish the clinical relevance of Etk-induced, hypoxia-mediated gene regulation, we next examined the Etk expression in keloid, a skin fibrotic model which harbors elevated level of VEGF and PAI-1. We found that Etk is overexpressed in keloid (but not in normal skin) tissues. The differential steady-state levels of Etk protein were further confirmed in primary cultures of fibroblasts derived from these tissues, suggesting a role of Etk in tissue fibrosis. Taken together, our results provide a further understanding of how Etk functions within multiple signaling cascades to govern adaptive cytoprotection against extracellular stress in different cell systems, salivary epithelial, brain endothelial cells, and dermal fibroblasts
This article has been cited by other articles:
![]() |
T. Tu, D. Thotala, L. Geng, D. E. Hallahan, and C. D. Willey Bone Marrow X Kinase-Mediated Signal Transduction in Irradiated Vascular Endothelium Cancer Res., April 15, 2008; 68(8): 2861 - 2869. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Clavijo, J.-L. Chen, K.-J. Kim, M. E. Reyland, and D. K. Ann Protein kinase C{delta}-dependent and -independent signaling in genotoxic response to treatment of desferroxamine, a hypoxia-mimetic agent Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2150 - C2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dai, O. Kim, Y. Xie, Z. Guo, K. Xu, B. Wang, X. Kong, J. Melamed, H. Chen, C. J. Bieberich, et al. Tyrosine Kinase Etk/BMX Is Up-regulated in Human Prostate Cancer and Its Overexpression Induces Prostate Intraepithelial Neoplasia in Mouse Cancer Res., August 15, 2006; 66(16): 8058 - 8064. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-V. Nguyen, J.-L. Chen, J. Zhong, K.-J. Kim, E. D. Crandall, Z. Borok, Y. Chen, and D. K. Ann SUMOylation Attenuates Sensitivity toward Hypoxia- or Desferroxamine-Induced Injury by Modulating Adaptive Responses in Salivary Epithelial Cells Am. J. Pathol., May 1, 2006; 168(5): 1452 - 1463. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |